文献速递糖尿病

2型糖尿病治疗状态与阿尔茨海默病及痴呆风险的关联

Importance of Treatment Status in Links Between Type 2 Diabetes and Alzheimer's Disease.
PubMed 文献 · Diabetes Care · 2019-03-04

基于阿尔茨海默病神经影像学倡议(ADNI)队列(N=1,289,基线无痴呆),按空腹血糖与用药史分为血糖正常、糖尿病前期、未治疗糖尿病和治疗后糖尿病四组,其中900人行腰穿检测脑脊液生物标志物。未治疗糖尿病组tau病理更重、进展为痴呆的风险高于血糖正常组,而治疗后糖尿病组未见该关联,提示治疗状态可能改变2型糖尿病与AD生物标志物及痴呆风险的关系。

要点

  • 未治疗糖尿病与tau病理升高及痴呆风险增加相关。
  • 治疗后糖尿病未显示与AD生物标志物及痴呆风险的类似关联。
  • 该研究为观察性设计,不能推断因果关系。

核心结论

  • 治疗状态可能改变2型糖尿病与AD生物标志物特征及痴呆风险之间的关系。
  • 未治疗糖尿病与tau病理升高和痴呆风险增加相关,而治疗后糖尿病则不然。

研究设计与样本

  • 研究基于阿尔茨海默病神经影像学倡议(ADNI)队列,共1,289名基线无痴呆的参与者。
  • 参与者接受健康评估、认知测试和MRI,其中900人接受腰穿检测脑脊液p-tau、t-tau和Aβ1-42。
  • 按空腹血糖和用药史分为血糖正常(EU)、糖尿病前期(PD)、未治疗糖尿病(UD)和治疗后糖尿病(TD)四组。

主要发现

  • 未治疗糖尿病组的p-tau、t-tau及p-tau/Aβ1-42水平高于EU、PD和TD组(P值<0.05)。
  • 未治疗糖尿病组的t-tau/Aβ1-42高于EU和PD组(P值<0.05)。
  • 未治疗糖尿病组进展为痴呆的比例高于EU组(风险比1.602[95%CI 1.057-2.429];P=0.026)。

临床怎么用

  • 对2型糖尿病患者应关注其治疗状态,未治疗糖尿病者可能需更重视痴呆风险评估。

局限性

  • 本研究为观察性研究,无法推断因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate relationships among type 2 diabetes treatment, Alzheimer's disease(AD) biomarkers, and risk for dementia. RESEARCH DESIGN AND METHODS: Participants were from the Alzheimer's Disease Neuroimaging Initiative (N = 1,289) and were dementia-free at baseline and underwent health assessment, cognitive testing, and MRI. A subset (n = 900) obtained a lumbar puncture to determine cerebrospinal fluid (CSF) phosphorylated tau (p-tau), total tau (t-tau), and β-amyloid 1-42 (Aβ1-42). Participants were grouped by fasting blood glucose and medication history: euglycemia (EU), prediabetes (PD), untreated diabetes (UD), and treated diabetes (TD). Relationships were investigated between treatment status and CSF biomarkers and risk for dementia. RESULTS: The UD group displayed greater p-tau, t-tau, and p-tau/Aβ1-42 levels than the EU, PD, and TD groups (P values <0.05) and higher t-tau/Aβ1-42 than the EU and PD groups (P values <0.05). The UD group progressed to dementia at higher rates than the EU group (hazard ratio 1.602 [95% CI 1.057-2.429]; P = 0.026). CONCLUSIONS: Treatment status may alter the relationship between type 2 diabetes and both AD biomarker profile and risk for dementia. UD is associated with elevated tau pathology and risk for dementia, whereas TD is not. Although this study is observational and therefore causality cannot be inferred, findings support the potential importance of treatment status in AD risk associated with type 2 diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. McIntosh EC, Nation DA. Importance of Treatment Status in Links Between Type 2 Diabetes and Alzheimer's Disease. Diabetes Care. 2019. PMID: 30833374. doi:10.2337/dc18-1399

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。